Allstate (NYSE:ALL) Price Target Raised to $187.00

Allstate (NYSE:ALL) had its target price increased by stock analysts at Barclays from $175.00 to $187.00 in a report issued on Thursday, Benzinga reports. The brokerage currently has an “underweight” rating on the insurance provider’s stock. Barclays‘s price objective would indicate a potential downside of 0.61% from the company’s previous close.

Other analysts have also recently issued reports about the company. The Goldman Sachs Group increased their target price on Allstate from $199.00 to $204.00 and gave the stock a “buy” rating in a research note on Thursday, August 15th. Evercore ISI increased their price target on Allstate from $191.00 to $195.00 and gave the company an “in-line” rating in a research note on Wednesday, October 9th. Wells Fargo & Company decreased their target price on Allstate from $177.00 to $175.00 and set an “equal weight” rating for the company in a research note on Friday, August 16th. JPMorgan Chase & Co. increased their price target on Allstate from $205.00 to $207.00 and gave the stock an “overweight” rating in a report on Thursday, October 10th. Finally, Roth Mkm restated a “buy” rating and set a $200.00 price objective on shares of Allstate in a research note on Wednesday, August 14th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $207.19.

Allstate Price Performance

NYSE ALL traded down $1.29 on Thursday, hitting $188.15. 2,021,742 shares of the company were exchanged, compared to its average volume of 1,537,895. The company has a current ratio of 0.36, a quick ratio of 0.36 and a debt-to-equity ratio of 0.49. The company has a market cap of $49.66 billion, a P/E ratio of 41.69, a P/E/G ratio of 1.74 and a beta of 0.48. The firm has a 50 day moving average of $188.69 and a two-hundred day moving average of $174.95. Allstate has a 1-year low of $125.63 and a 1-year high of $198.79.

Allstate (NYSE:ALL) last released its earnings results on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, topping analysts’ consensus estimates of $2.20 by $1.71. The firm had revenue of $16.63 billion during the quarter, compared to analyst estimates of $14.57 billion. Allstate had a net margin of 5.03% and a return on equity of 24.05%. During the same quarter in the previous year, the business earned $0.81 EPS. The business’s quarterly revenue was up 14.7% compared to the same quarter last year. On average, equities analysts predict that Allstate will post 15.19 EPS for the current year.

Insider Transactions at Allstate

In related news, EVP Elizabeth Brady sold 49,481 shares of Allstate stock in a transaction on Friday, August 16th. The shares were sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the transaction, the executive vice president now owns 19,163 shares in the company, valued at approximately $3,431,901.67. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, EVP Robert Toohey sold 16,682 shares of the company’s stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $180.17, for a total transaction of $3,005,595.94. Following the sale, the executive vice president now directly owns 4,873 shares in the company, valued at approximately $877,968.41. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Elizabeth Brady sold 49,481 shares of the company’s stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the sale, the executive vice president now owns 19,163 shares in the company, valued at $3,431,901.67. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 192,530 shares of company stock worth $34,967,665 in the last 90 days. 1.80% of the stock is currently owned by insiders.

Institutional Trading of Allstate

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Northwest Investment Counselors LLC purchased a new stake in Allstate in the 3rd quarter worth about $28,000. Catalyst Capital Advisors LLC purchased a new stake in Allstate in the 3rd quarter worth about $29,000. Versant Capital Management Inc raised its position in Allstate by 70.9% in the 2nd quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock worth $30,000 after purchasing an additional 78 shares during the period. Family Firm Inc. purchased a new stake in Allstate in the 2nd quarter worth about $38,000. Finally, MCF Advisors LLC increased its position in shares of Allstate by 33.9% during the second quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock worth $53,000 after acquiring an additional 84 shares during the period. 76.47% of the stock is owned by hedge funds and other institutional investors.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.